Chemical Formula | C31H30F2N8O3 |
Molecular Weight | 598.62 g/mol |
Physical State | Solid (usually) |
Appearance | White to off - white powder |
Solubility In Water | Low solubility |
Solubility In Organic Solvents | Soluble in some polar organic solvents like DMSO |
Logp | Calculated value would depend on software used for calculation |
What is the chemical structure of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cyclohepta [b] pyridin-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazo [4,5-b] pyridin-1-yl) piperidine-1-carboxylate
This is the chemical name of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylic acid ester. To clarify its chemical structure, it should be explained by organic chemistry.
This compound contains multiple specific groups and structural fragments. " (5S, 6S, 9R) " shows the configuration of the chiral center, which is related to the stereochemical properties of the molecule. " 5-Amino "refers to the amino group ($- NH_ {2} $) attached at a specific position. The amino group is nucleophilic and often plays an important role in chemical reactions.
" 6- (2,3-difluorophenyl) "table has a phenyl group with two fluorine atoms substituted at the 6 position. The fluorine atom has high electronegativity, which can affect the distribution of molecular electron clouds and physicochemical properties." 6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine "is a core heterocyclic structure. It is formed by fusing cycloheptane and pyridine rings, and some double bonds are hydrogenated. This structure gives the molecule a specific spatial shape and electron conjugation system.
"9-yl" indicates that this cycloheptopyridine structure is connected to other parts at the 9th position. "4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylate", piperidine ring is connected to carboxylic acid ester group at the 1st position, and imidazolopyridine structure is connected at the 4th position, and the imidazolopyridine ring is at the 2nd position. This complex structure further enriches the molecular chemical properties.
Overall, this compound has a complex structure, and the interaction of various groups determines its unique physical, chemical and biological activities. Its structural design may be of great research value in the fields of drug discovery and organic synthesis in order to obtain specific pharmacological activities or meet specific reaction requirements.
What is the main use of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cyclohepta [b] pyridin-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazo [4,5-b] pyridin-1-yl) piperidine-1-carboxylate
(5S, 6S, 9R) - 5-amino-6- (2,3-difluorophenyl) - 6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylate, which is the key to medical treatment and medicine.
In the way of medicine by physicians, it is mainly used for the treatment of specific diseases. If some biomolecular pathway disorders are involved in the pathogenesis of the disease, this drug can precisely fit with the relevant target by virtue of its unique chemical conformation. It is like a delicate tenon and tenon, entering the disease, or regulating protein activity, or correcting the deviation of cell signaling, so that the abnormal physiological function gradually returns to normal.
Pharmacists have developed this product to overcome intractable diseases. Looking at its structure, it is multi-cyclic and contains a variety of special groups. This delicate structure gives it specific pharmacological activity. After repeated tests and scrutiny, its metabolism and distribution in the body have been explored, and efforts have been made to achieve the best therapeutic effect and reduce its side effects. Its research and development process, as the ancient books say, is a collection of wisdom and hardships, just to get a good medicine and solve the suffering of patients.
This medicine is in the clinic, or the gospel of patients. However, when using medicine, doctors must carefully review the patient's physique and disease, weigh the pros and cons, and use precise medicine, in order to make this medicine play the greatest role, and contribute to the prosperity of medical science and the well-being of patients.
What are the synthesis methods of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cyclohepta [b] pyridin-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazo [4,5-b] pyridin-1-yl) piperidine-1-carboxylate
The synthesis of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylic acid esters is an important topic in the field of organic synthesis. The structure of this compound is complex, and it must follow a delicate path to achieve it. < Br >
At the beginning, the key skeleton is constructed by clever reaction with suitable starting materials. Or the compound containing difluorophenyl can be taken first, and it can be condensed with the precursor with the pyridine structure to form the cycloheptanopyridine part. In the meantime, the control of the reaction conditions is the key, such as temperature, solvent, catalyst, etc., all need to be precisely prepared. If the temperature is too high or the side reactions are clustered, if it is too low, the reaction will be slow and the yield will be low.
Then, the obtained intermediate is modified to introduce the piperidine-1-carboxylate fragment. This step may be achieved by acylation reaction, etc., and attention should also be paid to the selectivity of the reaction check point to avoid unnecessary by-products.
Then, under specific conditions, the imidazolopyridine structure is connected to the piperidine part to obtain the target product. In this process, the use of protective groups may be indispensable to ensure that each reaction step proceeds as expected, and the protective group is removed at an appropriate stage to restore the required active group.
The whole process of synthesis requires fine operation at every step. The product must be carefully separated and purified, and various analytical methods, such as chromatography and spectroscopy, are used to prove its structure and purity. In this way, the effective synthesis of this complex compound can be obtained.
What are the pharmacological properties of (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cyclohepta [b] pyridin-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazo [4,5-b] pyridin-1-yl) piperidine-1-carboxylate
(This medicine) is named (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylate, and its pharmacological properties are extraordinary. The pharmacological effect of this medicine is like a wonderful medicine in the hands of a good doctor, and it can be precisely administered.
Looking at its characteristics, it can act on specific biological targets, like a sharp arrow, which can regulate related physiological processes. At the cellular level, it can intervene in specific signaling pathways, like a pilot, so that cell activity returns to the right track. Its ability to bind to receptors is as stable as a rock, like a tenon-and-mortise fit, which triggers a series of biochemical reactions, or corrects abnormal metabolism, or regulates immune imbalance, like setting things right and returning the body to a healthy and balanced state.
Furthermore, the effect of this drug is highly efficient and specific. In the body, it has nothing to do with physiology and is dedicated to its duties, just like a specialized craftsman, who only carefully crafts the target, so there are few adverse reactions, just like the breeze blowing in the face, without disturbing other objects, which increases the value of its clinical application and brings new hope for the recovery of patients.
What is the market outlook for (5S, 6S, 9R) -5-amino-6- (2,3-difluorophenyl) -6,7,8,9-tetrahydro-5H-cyclohepta [b] pyridin-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazo [4,5-b] pyridin-1-yl) piperidine-1-carboxylate
(5S, 6S, 9R) - 5-amino-6- (2,3-difluorophenyl) - 6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylic acid ester, this is a complex organic compound.
In the field of pharmaceutical and chemical industry, the research and development of new compounds is as brilliant as Xinghan, emerging one after another. However, the market prospect of such complex compounds is often influenced by many factors. From the beginning of research and development, a lot of manpower, material resources and time need to be invested to study its pharmacological activity, safety and pharmacogenicity.
At the end of pharmacological activity, if it can accurately act on specific disease targets and demonstrate excellent efficacy, it is like a sharp sword hitting the key point, and the market potential is limitless. For example, if it can provide a new treatment path for a difficult-to-treat disease, such as rare diseases or malignant tumors, it will surely attract pharmaceutical companies to chase after it, which is expected to give birth to new drug categories and create a new treatment pattern.
Safety is also crucial. Even if the activity is extraordinary, if the safety is at risk, the side effects will be blocked by a tiger, and it will be difficult to enter the market stage. Preclinical and clinical trials must be rigorous and meticulous, and their toxic and side effects must be carefully investigated. Only by ensuring safety and reliability can they be approved by regulators, which in turn benefits patients.
Furthermore, the market competition situation is also the key. If the field involved in this compound is already crowded with giants, and there are many competing products, if you want to stand out, you must have unique advantages, or better curative effect, or less side effects, or more convenient dosing methods.
In addition, the production cost should not be underestimated. If the synthesis process is complicated, the raw materials are rare and expensive, and the cost is high, even if the curative effect is remarkable, the marketing activities will be limited due to the high price. Only by optimizing the process and reducing the cost can we have a stable place in the market competition.
In summary, the market prospect of (5S, 6S, 9R) - 5-amino-6- (2,3-difluorophenyl) - 6,7,8,9-tetrahydro-5H-cycloheptano [b] pyridine-9-yl 4- (2-oxo-2,3-dihydro-1H-imidazolo [4,5-b] pyridine-1-yl) piperidine-1-carboxylate requires comprehensive consideration of many factors such as pharmacological activity, safety, competition situation and production cost A clue.